James Trager
Chief Tech/Sci/R&D Officer bij NKARTA, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
James Trager is currently the Chief Scientific Officer at Nkarta, Inc. He previously worked at Dendreon Corp.
as the Senior Vice President-Research & Development from 2003 to 2019.
Trager holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from St. John's College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NKARTA, INC.
0.30% | 12-02-2024 | 149 415 ( 0.30% ) | 2 M $ | 31-03-2024 |
Actieve functies van James Trager
Bedrijven | Functie | Begin |
---|---|---|
NKARTA, INC. | Chief Tech/Sci/R&D Officer | 01-09-2016 |
Eerdere bekende functies van James Trager
Bedrijven | Functie | Einde |
---|---|---|
DENDREON CORPORATION | Chief Tech/Sci/R&D Officer | 01-12-2019 |
Opleiding van James Trager
University of California, Berkeley | Doctorate Degree |
St. John's College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NKARTA, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |